CRONOS GROUP INC. (CRON) Free cash flow
- Free cash flow · 12 months (USD): Value $49.82M; Formula and calculation Operating cash flow minus capital spending; distinct from the saved levered FCF quote figure. Period ending 2026-06-30..
- Price / free cash flow · 12 months: Value (m); Formula and calculation Market cap / trailing-year free cash flow; inverse of FCF yield before percent scaling. Period ending 2026-06-30..
- Free cash flow yield · 12 months: Value (m); Formula and calculation (Operating cash flow − capital spending) / current market cap. Period ending 2026-06-30..
- Free cash flow margin · 12 months: Value 27.82%; Formula and calculation (Operating cash flow − capital spending) / revenue. Period ending 2026-06-30..
Free cash flow
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Free cash flow · 12 months (USD) | $49.82M | Operating cash flow minus capital spending; distinct from the saved levered FCF quote figure. Period ending 2026-06-30. $60.05M − $10.24M ≈ $49.82M |
| Price / free cash flow · 12 months | (m) | Market cap / trailing-year free cash flow; inverse of FCF yield before percent scaling. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Free cash flow yield · 12 months | (m) | (Operating cash flow − capital spending) / current market cap. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Free cash flow margin · 12 months | 27.82% | (Operating cash flow − capital spending) / revenue. Period ending 2026-06-30. $49.82M ÷ $179.09M × 100 ≈ 27.82% |
| Free cash flow per share · 12 months | (m) | (Trailing-year operating cash flow − capital spending) / reported quarter-end common shares. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Operating cash flow · 12 months | $60.05M | Cash generated by operating activities. Period ending 2026-06-30. |
| Operating cash flow / net income · 12 months | 0.78× | Operating cash flow / net income. Period ending 2026-06-30. $60.05M ÷ $76.53M ≈ 0.78× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating cash flow | 60.05M USD | Net Cash Provided by (Used in) Operating Activities |
| Capital spending | 10.24M USD | Payments to Acquire Property, Plant, and Equipment |
| Market cap | (m) | |
| Free cash flow | 49.82M USD | Net Cash Provided by (Used in) Operating Activities · Payments to Acquire Property, Plant, and Equipment |
| Revenue | 179.09M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Quarter-end shares | (m) | Common Stock, Shares, Outstanding |
| Net income | 76.53M USD | Net Income (Loss) Attributable to Parent |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Free cash flow | FCF per share | Operating cash flow | Capital spending (USD) | Market cap (USD) | Revenue (USD) | Quarter-end shares (shares) | Net income (USD) | Price / FCF | FCF yield | FCF margin | Cash conversion |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $49.82M | (m) | $60.05M | $10.24M | (m) | $179.09M | (m) | $76.53M | (m) | (m) | 27.82% | 0.78× |
| 2026-03-31 | $26.53M | (m) | $38.86M | $12.33M | (m) | $159.53M | (m) | $4.73M | (m) | (m) | 16.63% | 8.22× |
| 2025-12-31 | $149.00K | (m) | $25.87M | $25.72M | (m) | $146.59M | (m) | $-9.45M | (m) | (m) | 0.10% | -2.74× |
| 2025-09-30 | $-5.37M | (m) | $21.75M | $27.12M | (m) | $132.36M | (m) | $36.10M | (m) | (m) | -4.06% | 0.60× |
| 2025-06-30 | $-9.03M | (m) | $20.02M | $29.05M | (m) | $130.28M | (m) | $18.49M | (m) | (m) | -6.93% | 1.08× |
| 2025-03-31 | $-6.99M | (m) | $18.95M | $25.95M | (m) | $124.59M | (m) | $49.44M | (m) | (m) | -5.61% | 0.38× |
| 2024-12-31 | $6.43M | (m) | $18.84M | $12.41M | (m) | $117.61M | (m) | $41.08M | (m) | (m) | 5.47% | 0.46× |
| 2024-09-30 | $17.85M | (m) | $27.94M | $10.09M | (m) | $111.23M | (m) | $-47.44M | (m) | (m) | 16.05% | -0.59× |
| 2024-06-30 | $12.51M | (m) | $16.17M | $3.66M | (m) | $101.78M | (m) | $-57.43M | (m) | (m) | 12.29% | -0.28× |
| 2024-03-31 | $-771.00K | (m) | $2.65M | $3.42M | (m) | $93.03M | (m) | $-57.03M | (m) | (m) | -0.83% | -0.05× |
| 2023-12-31 | $-45.34M | (m) | $-42.84M | $2.50M | (m) | $87.24M | (m) | $-73.96M | (m) | (m) | -51.97% | 0.58× |
| 2023-09-30 | $-85.67M | (m) | $-84.02M | $1.65M | (m) | $90.51M | (m) | $-108.06M | (m) | (m) | -94.65% | 0.78× |
| 2023-06-30 | $-99.75M | (m) | $-97.22M | $2.53M | (m) | $86.11M | (m) | $-143.40M | (m) | (m) | -115.84% | 0.68× |
| 2023-03-31 | $-106.27M | (m) | $-102.73M | $3.54M | (m) | $87.02M | (m) | $-155.26M | (m) | (m) | -122.13% | 0.66× |
| 2022-12-31 | $-92.40M | (m) | $-88.95M | $3.45M | (m) | $91.90M | (m) | $-168.73M | (m) | (m) | -100.54% | 0.53× |
| 2022-09-30 | $-104.09M | (m) | $-100.51M | $3.58M | (m) | $94.81M | (m) | $-223.49M | (m) | (m) | -109.79% | 0.45× |
| 2022-06-30 | $-123.63M | (m) | $-118.61M | $5.01M | (m) | $94.30M | (m) | $-108.58M | (m) | (m) | -131.10% | 1.09× |
| 2022-03-31 | $-146.09M | (m) | $-140.91M | $5.17M | (m) | $86.86M | (m) | $-267.43M | (m) | (m) | -168.19% | 0.53× |
| 2021-12-31 | $-164.76M | (m) | $-153.62M | $11.14M | (m) | $74.44M | (m) | $-396.11M | (m) | (m) | -221.35% | 0.39× |
| 2021-09-30 | $-174.32M | (m) | $-153.59M | $20.73M | (m) | $65.69M | (m) | $-373.70M | (m) | (m) | -265.39% | 0.41× |
| 2021-06-30 | $-176.69M | (m) | $-150.28M | $26.41M | (m) | $56.64M | (m) | $-146.46M | (m) | (m) | -311.97% | 1.03× |
| 2021-03-31 | $-181.24M | (m) | $-149.56M | $31.68M | (m) | $50.90M | (m) | $-310.49M | (m) | (m) | -356.09% | 0.48× |
| 2020-12-31 | $-173.87M | (m) | $-142.46M | $31.41M | (m) | $46.72M | (m) | $-73.14M | (m) | (m) | -372.16% | 1.95× |
| 2020-09-30 | $-180.27M | (m) | $-157.90M | $22.38M | (m) | $36.98M | (m) | $100.10M | (m) | (m) | -487.48% | -1.58× |
| 2020-06-30 | $-181.52M | (m) | $-150.43M | $31.09M | (m) | $31.41M | (m) | $635.48M | (m) | (m) | -577.95% | -0.24× |
| 2020-03-31 | $-190.02M | (m) | $-155.07M | $34.96M | (m) | $29.18M | (m) | $928.45M | (m) | (m) | -651.25% | -0.17× |
| 2019-12-31 | $-168.67M | (m) | $-130.01M | $38.66M | (m) | $23.75M | (m) | $1.17B | (m) | (m) | -710.19% | -0.11× |
| 2019-09-30 | (m) | (m) | (m) | (m) | (m) | $20.73M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-06-30 | (m) | (m) | (m) | (m) | (m) | $17.82M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-03-31 | (m) | (m) | (m) | (m) | (m) | $12.80M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | $-95.83M | (m) | $-7.52M | $88.31M | (m) | $12.12M | (m) | $-21.64M | (m) | (m) | -790.57% | 0.35× |
| 2017-12-31 | $-37.20M | (m) | $-4.28M | $32.93M | (m) | $3.15M | (m) | $-1.48M | (m) | (m) | -1182.21% | 2.88× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |